Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Leo Pharma delays IPO amid unfavorable markets: Bloomberg
Leo Pharma won't move forward with its plans for a 2026 IPO filing, as ownership opts to wait on a more favorable market.
Donavyn Coffey
Nov 16, 2026 2:52pm
Roche’s Gazyva wins first FDA nod for membranous nephropathy
Nov 16, 2026 11:00am
Digital Twins: Advancing Clinical Evidence Strategy
Brought to you by
IQVIA
Eisai, Linus Health launch ‘brain health’ digital resource
Nov 16, 2026 10:45am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nods
Nov 16, 2026 10:39am